NeoTract
NeoTract was a privately-held medical device company founded in 2004 that developed and commercialized the FDA-cleared UroLift System, a minimally invasive transurethral treatment for lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH). Teleflex Incorporated acquired NeoTract for up to $1.1 billion in October 2017; the UroLift product line now lives under Teleflex at urolift.com. Surfaced as a portfolio company of NEA. This is a physical medical-device business with no public developer, API, or SDK surface; the neotract.com domain no longer resolves.
NeoTract is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health, Medical Technology, and Medical.
Kin Score
Markets this provider is in provisional
The Kin Score Market layer reads a provider inside its market: its position, and how deep its integrations go. Depth is only comparable within a position. Provisional and unweighted: not part of the Kin Score or agent readiness.
| Market | Position | Depth | Registered MCP server | Declares compatibility |
|---|---|---|---|---|
| Canada Medical Device Licensing (Health Canada MDALL licence holders, incl. SaMD) | regulated | 21.5 (thin) | - | - |
Registered MCP server and declares compatibility are report only — not weighted. Undeclared means we found nothing we can read, so there is no number: we never infer integrations.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.